Richard K personal page - To The Moon

Richard K

No personal profile

7Follow

0Followers

0Topic

0Badge

2022-12-14

Let's see

Sorry, the original content has been removed

2022-12-08

$TENCENT(00700)$ MA line looks strong.

2022-12-07

Nice

Sorry, the original content has been removed

2022-10-28

$Tiger Brokers(TIGR)$gogogo do not get spooked. Looking bullish on $Golden Sun Education Group Limited(GSUN)$$XPeng Inc.(XPEV)$time to fly high

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4122126185735412","uuid":"4122126185735412","gmtCreate":1659023102265,"gmtModify":1659023102265,"name":"Richard K","pinyin":"richardkrichardk","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","hatId":"ca_profile_frame_DWr5S1","hatName":"","vip":1,"status":2,"fanSize":0,"headSize":7,"tweetSize":4,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":4,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.10.24","exceedPercentage":"80.34%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.76%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.04","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.13","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9921802409,"gmtCreate":1671018351602,"gmtModify":1676538476224,"author":{"id":"4122126185735412","authorId":"4122126185735412","name":"Richard K","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4122126185735412","authorIdStr":"4122126185735412"},"themes":[],"htmlText":"Let's see","listText":"Let's see","text":"Let's see","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9921802409","repostId":"2291479180","repostType":2,"isVote":1,"tweetType":1,"viewCount":365,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9920216292,"gmtCreate":1670501113417,"gmtModify":1676538381011,"author":{"id":"4122126185735412","authorId":"4122126185735412","name":"Richard K","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4122126185735412","authorIdStr":"4122126185735412"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/00700\">$TENCENT(00700)$&nbsp;</a><v-v data-views=\"1\"></v-v>MA line looks strong.","listText":"<a href=\"https://ttm.financial/S/00700\">$TENCENT(00700)$&nbsp;</a><v-v data-views=\"1\"></v-v>MA line looks strong.","text":"$TENCENT(00700)$ MA line looks strong.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9920216292","isVote":1,"tweetType":1,"viewCount":251,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9920980992,"gmtCreate":1670418269016,"gmtModify":1676538363629,"author":{"id":"4122126185735412","authorId":"4122126185735412","name":"Richard K","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4122126185735412","authorIdStr":"4122126185735412"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9920980992","repostId":"2289814769","repostType":2,"isVote":1,"tweetType":1,"viewCount":199,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9986225374,"gmtCreate":1666966972399,"gmtModify":1676537841695,"author":{"id":"4122126185735412","authorId":"4122126185735412","name":"Richard K","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4122126185735412","authorIdStr":"4122126185735412"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a><v-v data-views=\"1\"></v-v>gogogo do not get spooked. Looking bullish on&nbsp;<a href=\"https://ttm.financial/S/GSUN\">$Golden Sun Education Group Limited(GSUN)$</a><a href=\"https://ttm.financial/S/XPEV\">$XPeng Inc.(XPEV)$</a>time to fly high","listText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a><v-v data-views=\"1\"></v-v>gogogo do not get spooked. Looking bullish on&nbsp;<a href=\"https://ttm.financial/S/GSUN\">$Golden Sun Education Group Limited(GSUN)$</a><a href=\"https://ttm.financial/S/XPEV\">$XPeng Inc.(XPEV)$</a>time to fly high","text":"$Tiger Brokers(TIGR)$gogogo do not get spooked. Looking bullish on $Golden Sun Education Group Limited(GSUN)$$XPeng Inc.(XPEV)$time to fly high","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/9986225374","isVote":1,"tweetType":1,"viewCount":697,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4128003051062292","authorId":"4128003051062292","name":"大神通","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"idStr":"4128003051062292","authorIdStr":"4128003051062292"},"content":"Sb, xpev fell like a dog","text":"Sb, xpev fell like a dog","html":"Sb, xpev fell like a dog"}],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9986225374,"gmtCreate":1666966972399,"gmtModify":1676537841695,"author":{"id":"4122126185735412","authorId":"4122126185735412","name":"Richard K","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4122126185735412","idStr":"4122126185735412"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a><v-v data-views=\"1\"></v-v>gogogo do not get spooked. Looking bullish on&nbsp;<a href=\"https://ttm.financial/S/GSUN\">$Golden Sun Education Group Limited(GSUN)$</a><a href=\"https://ttm.financial/S/XPEV\">$XPeng Inc.(XPEV)$</a>time to fly high","listText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a><v-v data-views=\"1\"></v-v>gogogo do not get spooked. Looking bullish on&nbsp;<a href=\"https://ttm.financial/S/GSUN\">$Golden Sun Education Group Limited(GSUN)$</a><a href=\"https://ttm.financial/S/XPEV\">$XPeng Inc.(XPEV)$</a>time to fly high","text":"$Tiger Brokers(TIGR)$gogogo do not get spooked. Looking bullish on $Golden Sun Education Group Limited(GSUN)$$XPeng Inc.(XPEV)$time to fly high","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/9986225374","isVote":1,"tweetType":1,"viewCount":697,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4128003051062292","authorId":"4128003051062292","name":"大神通","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"4128003051062292","idStr":"4128003051062292"},"content":"Sb, xpev fell like a dog","text":"Sb, xpev fell like a dog","html":"Sb, xpev fell like a dog"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9920980992,"gmtCreate":1670418269016,"gmtModify":1676538363629,"author":{"id":"4122126185735412","authorId":"4122126185735412","name":"Richard K","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4122126185735412","idStr":"4122126185735412"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9920980992","repostId":"2289814769","repostType":2,"repost":{"id":"2289814769","pubTimestamp":1670427122,"share":"https://ttm.financial/m/news/2289814769?lang=&edition=fundamental","pubTime":"2022-12-07 23:32","market":"us","language":"en","title":"3 Supercharged Growth Stocks With 393% to 1,153% Upside in 2023, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2289814769","media":"Motley Fool","summary":"Select Wall Street analysts believe these fast-growing companies could skyrocket next year.","content":"<html><head></head><body><p>This has been a historic year for all the wrong reasons. The bond market has delivered its worst year on record, the <b>S&amp;P 500</b> produced its worst first-half return in 52 years, and the nation&#39;s central bank is aggressively raising interest rates as the stock market plunges. There simply haven&#39;t been many safe havens for investors.</p><p>Yet in spite of these challenges, most Wall Street analysts maintain an optimistic tone. The reason being that recessions and bear markets tend to be short-lived. With the major U.S. indexes eventually erasing corrections, crashes, and bear markets over time, it generally pays to be an optimist.</p><p>However, some analysts are taking optimism to an extreme. Based on the highest price targets issued by Wall Street, the following three supercharged growth stocks offer upside ranging between 393% and 1,153% in 2023.</p><h2>Plug Power: Implied upside of 393%</h2><p>The first fast-paced company with serious upside is hydrogen fuel-cell solution provider <b>Plug Power</b>. According to analyst Amit Dayal of H.C. Wainwright, Plug Power can reach $78. For those of you keeping score at home, this would work out to a near-quintupling in the company&#39;s share price in 2023.</p><p>Dayal&#39;s optimism stems from a number of catalysts. First and foremost is the ongoing shift by most developed countries toward a renewable-energy-driven future. Plug expects to play a key role in supplying fuel cells for vehicles and industrial equipment (e.g., forklifts), as well as building the infrastructure needed to support fuel cell vehicle refueling.</p><p>Additionally, Dayal is excited about management&#39;s efforts to improve operating margin while continuing to rapidly growing sales. Earlier this year, Dayal cited the opening of the company&#39;s fuel cell gigafactory in New York (this occurred in mid-November) and the rollout of next-generation GenDrive units, which are less costly to service, as reasons the company&#39;s margin can improve.</p><p>But the biggest catalyst of all might just be Plug Power&#39;s ability to forge partnerships and joint ventures. It landed an equity investment from SK Group in early 2021 and is working with <b>Renault</b> via a joint venture to go after a significant portion of Europe&#39;s light commercial vehicle market. These partnerships should help lift Plug from just over $500 million in sales in 2021 to a company-forecast $3 billion in revenue by 2025.</p><p>However -- and this is the <i>big</i> &#34;however&#34; -- Plug Power isn&#39;t profitable, and the growing likelihood of a U.S. recession, coupled with high inflation in most developed countries, could coerce businesses and governments to postpone their green-energy transition/spending to a later date.</p><p>With Plug Power already valued at north of $9 billion, a lot of its future sales growth appears to be baked in. Until the company can plant its proverbial feet in the ground and deliver on the bottom line, a $78 price target will be hard to justify.</p><h2>Bionano Genomics: Implied upside of 474%</h2><p>A second supercharged growth stock with monumental upside, at least according to one Wall Street analyst, is small-cap genome analysis company <b>Bionano Genomics</b>. If <b>Oppenheimer</b> analyst Francois Brisebois is correct, Bionano shares will hit $12 in 2023, which would represent an upside of a cool 474%.</p><p>Although Brisebois is the current analyst covering Bionano for Oppenheimer, it was his predecessor, Kevin DeGeeter, who primarily laid out the case for Bionano Genomics running to $12. In DeGeeter&#39;s view, Bionano&#39;s optical genome mapping (OGM) system, known as Saphyr, has demonstrated that it&#39;s faster, less expensive, and in many ways more effective at identifying structural genome variations than other OGM systems.</p><p>One thing investors don&#39;t have to worry about with Bionano Genomics is a lack of data demonstrating Saphyr&#39;s efficacy. Over the past two years, the company has released numerous studies and data points extolling Saphyr&#39;s ability to recognize structural variations in everything from various types of cancer to genetic disorders and recurrent pregnancy loss. In theory, Saphyr can play a key role in helping researchers and drug developers fight hard-to-treat diseases.</p><p>Another positive for Bionano Genomics is its healthy cash position. After its share price went parabolic to begin 2021, management wisely chose to issue stock to raise plenty of capital. The company ended September with approximately $180 million in cash, cash equivalents, and available-for-sale securities.  That&#39;s more than enough to offset quarterly losses as the company continues to innovate and look for ways to expand Saphyr&#39;s utility.</p><p>So, why is Bionano Genomics at $2.09 per share and not $12? The answer to that question largely has to do with Saphyr not being an approved diagnostic system by the U.S. Food and Drug Administration (FDA). Without this approval, Saphyr&#39;s utility is limited within the United States. It&#39;s not exactly clear if and when Saphyr might get the green light from the FDA, either.</p><p>Although Bionano&#39;s cash does provide a somewhat safe floor, the ceiling proposed by Brisebois and DeGeeter doesn&#39;t seem achievable without FDA support.</p><h2>Novavax: Implied upside of 1,153%</h2><p>The third supercharged growth stock with truly jaw-dropping upside potential, based on the price target of one analyst, is biotech stock <b>Novavax</b>. According to H.C. Wainwright analyst Vernon Bernardino, who last updated his firm&#39;s price target in March 2022, Novavax is poised to hit (drum roll) $207 per share. That represents a whopping 1,153% upside from where shares ended this past week.</p><p>Bernardino&#39;s price target, which sits as the high-water mark among covering analysts, was based on the idea that Novavax would receive authorization to sell its protein-based COVID-19 vaccine, NVX-CoV2373, worldwide. Whereas the <b>Moderna</b> and <b>Pfizer</b>/<b>BioNTech</b> vaccines rely on messenger-RNA (mRNA) technology, the Novavax vaccine is differentiated in that it relies on an older and more traditional application of introducing harmless pieces of spike protein to teach a person&#39;s immune system how to fight and/or prevent infection. The thinking here is that folks who were leery of getting an mRNA vaccine might be more willing to receive an initial series or booster shots from Novavax&#39;s protein-based COVID-19 vaccine.</p><p>Something else that&#39;s working in Novavax&#39;s favor is the efficacy of NVX-CoV2373. Only three COVID-19 vaccines have reached the highly coveted 90% vaccine efficacy (VE) level. Those being Moderna (94.1%), Pfizer/BioNTech (95%), and Novavax (90.4%) with its U.S./Mexico trial in 2021. Even though VE is just one measure of efficacy, it&#39;s a strong enough headline number to keep Novavax in the global rotation as a major initial series and booster vaccine player.</p><p>Similar to Bionano, Novavax is swimming with cash. The company ended the third quarter with $1.28 billion in cash and cash equivalents, which is more than enough to cover the future repayment of its convertible notes and fuel ongoing research.  In particular, Novavax could be one of the first drug developers to bring a combination vaccine targeting COVID-19 and influenza to market.</p><p>But even being a shareholder, I don&#39;t in any way foresee $207 as a viable price target for Novavax in 2023. With the company enduring numerous emergency-use filing delays and production snafus, it missed out on most of the low-hanging fruit in developed markets in 2022. Moving forward, it&#39;ll primarily be focusing its attention on recurring booster shots in developed countries and initial series vaccinations in emerging markets.</p><p>While I believe Novavax is an amazing value at its current share price, it could take a couple of quarters before Wall Street realizes that as well. If sales growth continues, losses shrink, and the company advances its combination vaccines, it could certainly end 2023 on a much higher note than it&#39;ll finish 2022.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Supercharged Growth Stocks With 393% to 1,153% Upside in 2023, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Supercharged Growth Stocks With 393% to 1,153% Upside in 2023, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-12-07 23:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/12/06/3-growth-stocks-with-393-to-1153-upside-in-2023/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>This has been a historic year for all the wrong reasons. The bond market has delivered its worst year on record, the S&P 500 produced its worst first-half return in 52 years, and the nation's central ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/12/06/3-growth-stocks-with-393-to-1153-upside-in-2023/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","BNGO":"Bionano Genomics","PLUG":"普拉格能源"},"source_url":"https://www.fool.com/investing/2022/12/06/3-growth-stocks-with-393-to-1153-upside-in-2023/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2289814769","content_text":"This has been a historic year for all the wrong reasons. The bond market has delivered its worst year on record, the S&P 500 produced its worst first-half return in 52 years, and the nation's central bank is aggressively raising interest rates as the stock market plunges. There simply haven't been many safe havens for investors.Yet in spite of these challenges, most Wall Street analysts maintain an optimistic tone. The reason being that recessions and bear markets tend to be short-lived. With the major U.S. indexes eventually erasing corrections, crashes, and bear markets over time, it generally pays to be an optimist.However, some analysts are taking optimism to an extreme. Based on the highest price targets issued by Wall Street, the following three supercharged growth stocks offer upside ranging between 393% and 1,153% in 2023.Plug Power: Implied upside of 393%The first fast-paced company with serious upside is hydrogen fuel-cell solution provider Plug Power. According to analyst Amit Dayal of H.C. Wainwright, Plug Power can reach $78. For those of you keeping score at home, this would work out to a near-quintupling in the company's share price in 2023.Dayal's optimism stems from a number of catalysts. First and foremost is the ongoing shift by most developed countries toward a renewable-energy-driven future. Plug expects to play a key role in supplying fuel cells for vehicles and industrial equipment (e.g., forklifts), as well as building the infrastructure needed to support fuel cell vehicle refueling.Additionally, Dayal is excited about management's efforts to improve operating margin while continuing to rapidly growing sales. Earlier this year, Dayal cited the opening of the company's fuel cell gigafactory in New York (this occurred in mid-November) and the rollout of next-generation GenDrive units, which are less costly to service, as reasons the company's margin can improve.But the biggest catalyst of all might just be Plug Power's ability to forge partnerships and joint ventures. It landed an equity investment from SK Group in early 2021 and is working with Renault via a joint venture to go after a significant portion of Europe's light commercial vehicle market. These partnerships should help lift Plug from just over $500 million in sales in 2021 to a company-forecast $3 billion in revenue by 2025.However -- and this is the big \"however\" -- Plug Power isn't profitable, and the growing likelihood of a U.S. recession, coupled with high inflation in most developed countries, could coerce businesses and governments to postpone their green-energy transition/spending to a later date.With Plug Power already valued at north of $9 billion, a lot of its future sales growth appears to be baked in. Until the company can plant its proverbial feet in the ground and deliver on the bottom line, a $78 price target will be hard to justify.Bionano Genomics: Implied upside of 474%A second supercharged growth stock with monumental upside, at least according to one Wall Street analyst, is small-cap genome analysis company Bionano Genomics. If Oppenheimer analyst Francois Brisebois is correct, Bionano shares will hit $12 in 2023, which would represent an upside of a cool 474%.Although Brisebois is the current analyst covering Bionano for Oppenheimer, it was his predecessor, Kevin DeGeeter, who primarily laid out the case for Bionano Genomics running to $12. In DeGeeter's view, Bionano's optical genome mapping (OGM) system, known as Saphyr, has demonstrated that it's faster, less expensive, and in many ways more effective at identifying structural genome variations than other OGM systems.One thing investors don't have to worry about with Bionano Genomics is a lack of data demonstrating Saphyr's efficacy. Over the past two years, the company has released numerous studies and data points extolling Saphyr's ability to recognize structural variations in everything from various types of cancer to genetic disorders and recurrent pregnancy loss. In theory, Saphyr can play a key role in helping researchers and drug developers fight hard-to-treat diseases.Another positive for Bionano Genomics is its healthy cash position. After its share price went parabolic to begin 2021, management wisely chose to issue stock to raise plenty of capital. The company ended September with approximately $180 million in cash, cash equivalents, and available-for-sale securities.  That's more than enough to offset quarterly losses as the company continues to innovate and look for ways to expand Saphyr's utility.So, why is Bionano Genomics at $2.09 per share and not $12? The answer to that question largely has to do with Saphyr not being an approved diagnostic system by the U.S. Food and Drug Administration (FDA). Without this approval, Saphyr's utility is limited within the United States. It's not exactly clear if and when Saphyr might get the green light from the FDA, either.Although Bionano's cash does provide a somewhat safe floor, the ceiling proposed by Brisebois and DeGeeter doesn't seem achievable without FDA support.Novavax: Implied upside of 1,153%The third supercharged growth stock with truly jaw-dropping upside potential, based on the price target of one analyst, is biotech stock Novavax. According to H.C. Wainwright analyst Vernon Bernardino, who last updated his firm's price target in March 2022, Novavax is poised to hit (drum roll) $207 per share. That represents a whopping 1,153% upside from where shares ended this past week.Bernardino's price target, which sits as the high-water mark among covering analysts, was based on the idea that Novavax would receive authorization to sell its protein-based COVID-19 vaccine, NVX-CoV2373, worldwide. Whereas the Moderna and Pfizer/BioNTech vaccines rely on messenger-RNA (mRNA) technology, the Novavax vaccine is differentiated in that it relies on an older and more traditional application of introducing harmless pieces of spike protein to teach a person's immune system how to fight and/or prevent infection. The thinking here is that folks who were leery of getting an mRNA vaccine might be more willing to receive an initial series or booster shots from Novavax's protein-based COVID-19 vaccine.Something else that's working in Novavax's favor is the efficacy of NVX-CoV2373. Only three COVID-19 vaccines have reached the highly coveted 90% vaccine efficacy (VE) level. Those being Moderna (94.1%), Pfizer/BioNTech (95%), and Novavax (90.4%) with its U.S./Mexico trial in 2021. Even though VE is just one measure of efficacy, it's a strong enough headline number to keep Novavax in the global rotation as a major initial series and booster vaccine player.Similar to Bionano, Novavax is swimming with cash. The company ended the third quarter with $1.28 billion in cash and cash equivalents, which is more than enough to cover the future repayment of its convertible notes and fuel ongoing research.  In particular, Novavax could be one of the first drug developers to bring a combination vaccine targeting COVID-19 and influenza to market.But even being a shareholder, I don't in any way foresee $207 as a viable price target for Novavax in 2023. With the company enduring numerous emergency-use filing delays and production snafus, it missed out on most of the low-hanging fruit in developed markets in 2022. Moving forward, it'll primarily be focusing its attention on recurring booster shots in developed countries and initial series vaccinations in emerging markets.While I believe Novavax is an amazing value at its current share price, it could take a couple of quarters before Wall Street realizes that as well. If sales growth continues, losses shrink, and the company advances its combination vaccines, it could certainly end 2023 on a much higher note than it'll finish 2022.","news_type":1},"isVote":1,"tweetType":1,"viewCount":199,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9921802409,"gmtCreate":1671018351602,"gmtModify":1676538476224,"author":{"id":"4122126185735412","authorId":"4122126185735412","name":"Richard K","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4122126185735412","idStr":"4122126185735412"},"themes":[],"htmlText":"Let's see","listText":"Let's see","text":"Let's see","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9921802409","repostId":"2291479180","repostType":2,"repost":{"id":"2291479180","pubTimestamp":1671003913,"share":"https://ttm.financial/m/news/2291479180?lang=&edition=fundamental","pubTime":"2022-12-14 15:45","market":"us","language":"en","title":"Nasdaq Bear Market: 2 Stocks I'd Buy With No Hesitation","url":"https://stock-news.laohu8.com/highlight/detail?id=2291479180","media":"Motley Fool","summary":"After shocking 2022 declines, these stocks could move markets in 2023.","content":"<html><head></head><body><p>The question is asked often these days. &#34;How will we know when the bear market is over?&#34; Unfortunately, investors will only know this once the market reaches new highs -- and that&#39;s too late to harvest the most fruitful profits.</p><p>There isn&#39;t a reliable way to know when the market has reached its lows (if there were, the market wouldn&#39;t really work, right?). But there is one thing we <i>do</i> know. It will end, and we will thank ourselves for buying first-rate companies at a discount when it does.</p><p>The <b>Nasdaq Composite</b> is down more than 30% year to date, marking its most significant drawdown from its high since the Great Recession, as shown below.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b8938e25f83281e22b782f6a0602d2e5\" tg-width=\"720\" tg-height=\"433\" referrerpolicy=\"no-referrer\"/><span>^IXIC data by YCharts</span></p><p>While it could still fall further, this is a tremendous opportunity for investors to dollar-cost average into positions. After all, those who didn&#39;t hit the exact bottom of previous drawdowns are sitting on massive profits. Here is the same chart from above in actual dollars.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c49216266002a73e18de4881ed4c0000\" tg-width=\"720\" tg-height=\"433\" referrerpolicy=\"no-referrer\"/><span>^IXIC data by YCharts</span></p><p>As this shows, timing a bottom isn&#39;t necessary; disciplined investing in the world&#39;s preeminent companies consistently is. <b><a href=\"https://laohu8.com/S/ADBE\">Adobe</a></b> and <b>Walt Disney</b> are two beaten-down examples.</p><h2>Adobe looks unreasonably discounted</h2><p>Last year, more than 400 billion PDFs were opened, 90% of creative professionals rely on Adobe Photoshop, and 165 million folks have joined the creative economy since 2020. Fresh content is vital for businesses, advertisers, creative professionals, and others, and Adobe products make it happen.</p><p>Meanwhile, the company reported record fiscal third-quarter 2022 revenue ($4.43 billion on 13% growth), generally accepted accounting principles (GAAP) operating income of $1.5 billion, and cash from operations of $1.7 billion (up 20% year over year). This doesn&#39;t seem like a troubled business. Yet, the stock is down 41% year to date.</p><p>Much of the decline stems from Wall Street&#39;s short-sighted, pessimistic reaction to Adobe acquiring cloud-based design software company Figma. The price for Figma was steep at 50 times expected 2022 sales, but there is much more than meets the eye.</p><p>This deal is forward-looking because it allows Adobe to:</p><ul><li>Stay on the cutting edge. Tech workers love Figma, and this deal nets Adobe perhaps the best collaborative real-time editing software on the market.</li><li>Leverage Figma&#39;s 100% annual recurring revenue growth, 90% gross margins, and estimated $16.5 billion 2025 annual addressable market.</li><li>Keep Figma out of the hands of competitors.</li></ul><p>The deal that now looks expensive may be considered prescient in a few short years.</p><p>As shown below, Adobe stock trades well off its average price-to-earnings and price-to-free-cash-flow ratios.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8d4d82de3550f96f2e97ab9f9e382828\" tg-width=\"720\" tg-height=\"463\" referrerpolicy=\"no-referrer\"/><span>ADBE PE Ratio data by YCharts</span></p><p>It&#39;s time for investors to consider Adobe for the long term.</p><h2>Former CEO returns to turn around Disney</h2><p>Disney shocked the market just before Thanksgiving with the return of former CEO Bob Iger. Investors hope this can spur results as the stock trades near its March 2020 pandemic crash lows and down 40% year to date.</p><p>Iger will earn just $1 million in salary, but annual stock awards are targeted at $25 million annually. This stock-based compensation keeps his goals aligned with those of long-suffering shareholders.</p><p>Disney structures itself in two segments. Media and entertainment distribution (media) sales stem from licensing, cable television channels (ABC, ESPN, Disney Channel, etc.), and streaming services like Disney+, Hulu, and ESPN+. Meanwhile, the parks, experiences, and products (experiences) division encompasses theme parks, cruises, and resorts.</p><p>The experiences segment&#39;s sales and profits have fully recovered from the pandemic, reaching new highs in fiscal 2022, as shown in the chart below.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c12ada3e49ff0e4334e6ba8bdc2735fd\" tg-width=\"700\" tg-height=\"269\" referrerpolicy=\"no-referrer\"/><span>Data source: Disney. Chart by author.</span></p><p>The streaming wars are on and taking a toll on Disney&#39;s media profits. Sales rose 8% to $55 billion, but operating income fell 42% to just $4.2 billion in fiscal 2022. Disney is going toe to toe with Netflix, adding 57 million subscribers in fiscal 2022 to reach 235 million subscribers across its platforms.</p><p>With Iger back in the fold, Disney+ is looking to increase profits with its new ad-supported subscription offering. According to Statista, 45% of subscribers plan to use the lower-cost ad-supported plan, which could be a significant boon to Disney&#39;s profits. Iger has also pledged to empower the company&#39;s creators and restructure costs.</p><p>The turnaround won&#39;t happen overnight -- there is much work to do. Investors can take solace that Disney is determined to change, and the stock can be bought near its pandemic-crash lows. One thing is sure: The Disney brand is irreplaceable.</p><p>Bear markets are disheartening. No one likes to see hard-earned money slipping away. But there are terrific values available. Even though the market can&#39;t go up every year, it&#39;s still the best long-term wealth-building mechanism around.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nasdaq Bear Market: 2 Stocks I'd Buy With No Hesitation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNasdaq Bear Market: 2 Stocks I'd Buy With No Hesitation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-12-14 15:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/12/13/nasdaq-bear-market-2-stocks-id-buy-with-no-hesitat/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The question is asked often these days. \"How will we know when the bear market is over?\" Unfortunately, investors will only know this once the market reaches new highs -- and that's too late to ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/12/13/nasdaq-bear-market-2-stocks-id-buy-with-no-hesitat/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ADBE":"Adobe","SG9999015945.SGD":"LionGlobal Disruptive Innovation Fund A SGD","SG9999015986.USD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (USD) ACC","BK4528":"SaaS概念","SG9999015978.USD":"利安颠覆性创新基金A","LU1267930573.SGD":"TEMPLETON GLOBAL \"AA\" (SGD) ACC A","LU0158827948.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"A\" (USD) INC","BK4023":"应用软件","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","LU1691799644.USD":"Amundi Funds Polen Capital Global Growth A2 (C) USD","LU2089283258.USD":"安联环球可持续基金Cl AM Dis","LU0786609619.USD":"高盛全球千禧一代股票组合Acc","BK4567":"ESG概念","BK4108":"电影和娱乐","BK4585":"ETF&股票定投概念","LU0708994859.HKD":"TEMPLETON GLOBAL \"A\" (HKD) ACC","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","LU1815333072.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"AUP\" (USD) INC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0957791311.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"ZU\" (USD) ACC","BK4566":"资本集团","LU0029864427.USD":"TEMPLETON GLOBAL \"A\" (USD) INC","BK4524":"宅经济概念","LU0128525929.USD":"TEMPLETON GLOBAL \"A\" (USD) ACC","BK4527":"明星科技股","SG9999015952.SGD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (SGD) ACC","BK4550":"红杉资本持仓","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU2023251221.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (USD) INC","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","BK4551":"寇图资本持仓","LU1623119135.USD":"Natixis Mirova Global Sustainable Equity R-NPF/A USD","LU0310800379.SGD":"FTIF - Templeton Global A Acc SGD","LU0061474960.USD":"天利环球焦点基金AU Acc","LU1712237335.SGD":"Natixis Mirova Global Sustainable Equity H-R-NPF/A SGD","BK4561":"索罗斯持仓","LU2089284900.SGD":"Allianz Global Sustainability Cl AM Dis H2-SGD","DIS":"迪士尼","BK4581":"高盛持仓"},"source_url":"https://www.fool.com/investing/2022/12/13/nasdaq-bear-market-2-stocks-id-buy-with-no-hesitat/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2291479180","content_text":"The question is asked often these days. \"How will we know when the bear market is over?\" Unfortunately, investors will only know this once the market reaches new highs -- and that's too late to harvest the most fruitful profits.There isn't a reliable way to know when the market has reached its lows (if there were, the market wouldn't really work, right?). But there is one thing we do know. It will end, and we will thank ourselves for buying first-rate companies at a discount when it does.The Nasdaq Composite is down more than 30% year to date, marking its most significant drawdown from its high since the Great Recession, as shown below.^IXIC data by YChartsWhile it could still fall further, this is a tremendous opportunity for investors to dollar-cost average into positions. After all, those who didn't hit the exact bottom of previous drawdowns are sitting on massive profits. Here is the same chart from above in actual dollars.^IXIC data by YChartsAs this shows, timing a bottom isn't necessary; disciplined investing in the world's preeminent companies consistently is. Adobe and Walt Disney are two beaten-down examples.Adobe looks unreasonably discountedLast year, more than 400 billion PDFs were opened, 90% of creative professionals rely on Adobe Photoshop, and 165 million folks have joined the creative economy since 2020. Fresh content is vital for businesses, advertisers, creative professionals, and others, and Adobe products make it happen.Meanwhile, the company reported record fiscal third-quarter 2022 revenue ($4.43 billion on 13% growth), generally accepted accounting principles (GAAP) operating income of $1.5 billion, and cash from operations of $1.7 billion (up 20% year over year). This doesn't seem like a troubled business. Yet, the stock is down 41% year to date.Much of the decline stems from Wall Street's short-sighted, pessimistic reaction to Adobe acquiring cloud-based design software company Figma. The price for Figma was steep at 50 times expected 2022 sales, but there is much more than meets the eye.This deal is forward-looking because it allows Adobe to:Stay on the cutting edge. Tech workers love Figma, and this deal nets Adobe perhaps the best collaborative real-time editing software on the market.Leverage Figma's 100% annual recurring revenue growth, 90% gross margins, and estimated $16.5 billion 2025 annual addressable market.Keep Figma out of the hands of competitors.The deal that now looks expensive may be considered prescient in a few short years.As shown below, Adobe stock trades well off its average price-to-earnings and price-to-free-cash-flow ratios.ADBE PE Ratio data by YChartsIt's time for investors to consider Adobe for the long term.Former CEO returns to turn around DisneyDisney shocked the market just before Thanksgiving with the return of former CEO Bob Iger. Investors hope this can spur results as the stock trades near its March 2020 pandemic crash lows and down 40% year to date.Iger will earn just $1 million in salary, but annual stock awards are targeted at $25 million annually. This stock-based compensation keeps his goals aligned with those of long-suffering shareholders.Disney structures itself in two segments. Media and entertainment distribution (media) sales stem from licensing, cable television channels (ABC, ESPN, Disney Channel, etc.), and streaming services like Disney+, Hulu, and ESPN+. Meanwhile, the parks, experiences, and products (experiences) division encompasses theme parks, cruises, and resorts.The experiences segment's sales and profits have fully recovered from the pandemic, reaching new highs in fiscal 2022, as shown in the chart below.Data source: Disney. Chart by author.The streaming wars are on and taking a toll on Disney's media profits. Sales rose 8% to $55 billion, but operating income fell 42% to just $4.2 billion in fiscal 2022. Disney is going toe to toe with Netflix, adding 57 million subscribers in fiscal 2022 to reach 235 million subscribers across its platforms.With Iger back in the fold, Disney+ is looking to increase profits with its new ad-supported subscription offering. According to Statista, 45% of subscribers plan to use the lower-cost ad-supported plan, which could be a significant boon to Disney's profits. Iger has also pledged to empower the company's creators and restructure costs.The turnaround won't happen overnight -- there is much work to do. Investors can take solace that Disney is determined to change, and the stock can be bought near its pandemic-crash lows. One thing is sure: The Disney brand is irreplaceable.Bear markets are disheartening. No one likes to see hard-earned money slipping away. But there are terrific values available. Even though the market can't go up every year, it's still the best long-term wealth-building mechanism around.","news_type":1},"isVote":1,"tweetType":1,"viewCount":365,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9920216292,"gmtCreate":1670501113417,"gmtModify":1676538381011,"author":{"id":"4122126185735412","authorId":"4122126185735412","name":"Richard K","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4122126185735412","idStr":"4122126185735412"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/00700\">$TENCENT(00700)$&nbsp;</a><v-v data-views=\"1\"></v-v>MA line looks strong.","listText":"<a href=\"https://ttm.financial/S/00700\">$TENCENT(00700)$&nbsp;</a><v-v data-views=\"1\"></v-v>MA line looks strong.","text":"$TENCENT(00700)$ MA line looks strong.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9920216292","isVote":1,"tweetType":1,"viewCount":251,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}